Altis Biosystems
Durham · Founded 2015
About Altis Biosystems
Altis Biosystems is a biotechnology company developing research tools for the pharma and biotech industries. The company has developed a patent-pending stem cell technology recreating the human intestinal epithelium for compound screening and microbiome research. The product produces a layer of human or animal intestinal stem and differentiated cells, either of the small or large intestine. These cells can be used for disease modelling, precision medicine, microbiome research, and compound screening.
Company Facts
- Founded: 2015
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $6.7M
- Last round: Series Unknown (Apr 2025)
- Website: altisbiosystems.com
- Phone: +1 (919) 885-4823
Industries & Categories
Biotechnology, Life Science, Nanotechnology
Social Profiles
Canonical: https://fsome.com/organization/altis-biosystems-36133 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.